ACTINIUM PHARMACEUTICALS TO SHOWCASE ATNM-400'S FIRST-IN-HUMAN CLINICAL DATA IN PROSTATE CANCER AND PRECLINICAL RESULTS IN LUNG CANCER SUPPORTING PAN-TUMOR POTENTIAL TODAY AT EANM 2026

Reuters · 2d ago

Please log in to view news